L Lenchik1, T C Register2, G B Russell3, J Xu4, S C Smith4, D W Bowden4, J Divers3, B I Freedman5. 1. Department of Radiology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1053, USA. llenchik@wakehealth.edu. 2. Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA. 3. Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA. 4. Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA. 5. Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Abstract
The study showed that in African-American men with type 2 diabetes mellitus (T2D), vertebral volumetric bone mineral density (vBMD) predicts all-cause mortality, independent of other risk factors for death. INTRODUCTION: Compared to European Americans, African Americans have lower rates of osteoporosis and higher rates of T2D. The relationships between BMD and fractures with mortality are unknown in this population. The aim of this study was to determine relationships between vertebral fractures and vertebral vBMD and mortality in African Americans with T2D. METHODS: Associations between vertebral fractures and vBMD with all-cause mortality were examined in 675 participants with T2D (391 women and 284 men) in the African American-Diabetes Heart Study (AA-DHS). Lumbar and thoracic vBMD were measured using quantitative computed tomography (QCT). Vertebral fractures were assessed on sagittal CT images. Associations of vertebral fractures and vBMD with all-cause mortality were determined in sex-stratified analyses and in the full sample. Covariates in a minimally adjusted model included age, sex, BMI, smoking, and alcohol use; the full model was adjusted for those variables plus cardiovascular disease, hypertension, coronary artery calcified plaque, hormone replacement therapy (women), African ancestry proportion, and eGFR. RESULTS: After mean 7.6 ± 1.8-year follow-up, 59 (15.1%) of women and 58 (20.4%) of men died. In men, vBMD was inversely associated with mortality in the fully adjusted model: lumbar hazard ratio (HR) per standard deviation (SD) = 0.70 (95% CI 0.52-0.95, p = 0.02) and thoracic HR per SD = 0.71 (95% CI 0.54-0.92, p = 0.01). Only trends toward association between vBMD and mortality were observed in the combined sample of men and women, as significant associations were absent in women. Vertebral fractures were not associated with mortality in either sex. CONCLUSIONS: Lower vBMD was associated with increased all-cause mortality in African-American men with T2D, independent of other risk factors for mortality including subclinical atherosclerosis.
The study showed that in African-American men with type 2 diabetes mellitus (T2D), vertebral volumetric bone mineral density (vBMD) predicts all-cause mortality, independent of other risk factors for death. INTRODUCTION: Compared to European Americans, African Americans have lower rates of osteoporosis and higher rates of T2D. The relationships between BMD and fractures with mortality are unknown in this population. The aim of this study was to determine relationships between vertebral fractures and vertebral vBMD and mortality in African Americans with T2D. METHODS: Associations between vertebral fractures and vBMD with all-cause mortality were examined in 675 participants with T2D (391 women and 284 men) in the African American-Diabetes Heart Study (AA-DHS). Lumbar and thoracic vBMD were measured using quantitative computed tomography (QCT). Vertebral fractures were assessed on sagittal CT images. Associations of vertebral fractures and vBMD with all-cause mortality were determined in sex-stratified analyses and in the full sample. Covariates in a minimally adjusted model included age, sex, BMI, smoking, and alcohol use; the full model was adjusted for those variables plus cardiovascular disease, hypertension, coronary artery calcified plaque, hormone replacement therapy (women), African ancestry proportion, and eGFR. RESULTS: After mean 7.6 ± 1.8-year follow-up, 59 (15.1%) of women and 58 (20.4%) of men died. In men, vBMD was inversely associated with mortality in the fully adjusted model: lumbar hazard ratio (HR) per standard deviation (SD) = 0.70 (95% CI 0.52-0.95, p = 0.02) and thoracic HR per SD = 0.71 (95% CI 0.54-0.92, p = 0.01). Only trends toward association between vBMD and mortality were observed in the combined sample of men and women, as significant associations were absent in women. Vertebral fractures were not associated with mortality in either sex. CONCLUSIONS: Lower vBMD was associated with increased all-cause mortality in African-American men with T2D, independent of other risk factors for mortality including subclinical atherosclerosis.
Entities:
Keywords:
African American; Bone mineral density; Gender; Mortality; Quantitative computed tomography; Type 2 diabetes; Vertebral fracture
Authors: Heather M Ochs-Balcom; Leah Preus; Jean Wactawski-Wende; Jing Nie; Nicholas A Johnson; Fouad Zakharia; Hua Tang; Chris Carlson; Cara Carty; Zhao Chen; Thomas Hoffman; Carolyn M Hutter; Rebecca D Jackson; Robert C Kaplan; Li Li; Song Liu; Marian L Neuhouser; Ulrike Peters; John Robbins; Michael F Seldin; Timothy A Thornton; Cheryl L Thompson; Charles Kooperberg; Lara E Sucheston Journal: J Clin Endocrinol Metab Date: 2013-02-22 Impact factor: 5.958
Authors: Natalia Campos-Obando; Martha C Castano-Betancourt; Ling Oei; Oscar H Franco; Bruno H Ch Stricker; Guy G Brusselle; Lies Lahousse; Albert Hofman; Henning Tiemeier; Fernando Rivadeneira; André G Uitterlinden; M Carola Zillikens Journal: J Clin Endocrinol Metab Date: 2014-02-25 Impact factor: 5.958
Authors: Leon Lenchik; Thomas C Register; Fang-Chi Hsu; Jianzhao Xu; S Carrie Smith; J Jeffrey Carr; Barry I Freedman; Donald W Bowden Journal: J Clin Densitom Date: 2017-12-01 Impact factor: 2.617
Authors: H Johansson; A Odén; J Kanis; E McCloskey; M Lorentzon; Ö Ljunggren; M K Karlsson; E Orwoll; Å Tivesten; C Ohlsson; D Mellström Journal: Osteoporos Int Date: 2010-06-29 Impact factor: 4.507
Authors: Barry I Freedman; Jasmin Divers; Gregory B Russell; Nicholette D Palmer; Lynne E Wagenknecht; S Carrie Smith; Jianzhao Xu; J Jeffrey Carr; Donald W Bowden; Thomas C Register Journal: J Clin Endocrinol Metab Date: 2015-07-21 Impact factor: 5.958
Authors: Laura M Raffield; Fang-Chi Hsu; Amanda J Cox; J Jeffrey Carr; Barry I Freedman; Donald W Bowden Journal: Diabetol Metab Syndr Date: 2015-06-28 Impact factor: 3.320